301 related articles for article (PubMed ID: 38146118)
1. Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC).
Paniskaki K; Goretzki S; Anft M; Konik MJ; Meister TL; Pfaender S; Lechtenberg K; Vogl M; Dogan B; Dolff S; Westhoff TH; Rohn H; Felderhoff-Mueser U; Stervbo U; Witzke O; Dohna-Schwake C; Babel N
Pediatr Allergy Immunol; 2023 Dec; 34(12):e14060. PubMed ID: 38146118
[TBL] [Abstract][Full Text] [Related]
2. Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19.
Paniskaki K; Konik MJ; Anft M; Heidecke H; Meister TL; Pfaender S; Krawczyk A; Zettler M; Jäger J; Gaeckler A; Dolff S; Westhoff TH; Rohn H; Stervbo U; Scheibenbogen C; Witzke O; Babel N
Front Microbiol; 2023; 14():1196721. PubMed ID: 37333646
[TBL] [Abstract][Full Text] [Related]
3. Long COVID in pediatrics-epidemiology, diagnosis, and management.
Toepfner N; Brinkmann F; Augustin S; Stojanov S; Behrends U
Eur J Pediatr; 2024 Apr; 183(4):1543-1553. PubMed ID: 38279014
[TBL] [Abstract][Full Text] [Related]
4. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein.
Visvabharathy L; Hanson BA; Orban ZS; Lim PH; Palacio NM; Jimenez M; Clark JR; Graham EL; Liotta EM; Tachas G; Penaloza-MacMaster P; Koralnik IJ
Front Immunol; 2023; 14():1155770. PubMed ID: 37313412
[TBL] [Abstract][Full Text] [Related]
5. Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients.
Nasrullah A; Virk S; Javed A; Shah A; Ramanujam D; Sharma A; Gutierrez L; Nauer K; Maggio M; Yin Y; Bajwa Y; Cheema T; Disilvio B
BMC Pulm Med; 2024 May; 24(1):231. PubMed ID: 38745298
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
[TBL] [Abstract][Full Text] [Related]
7. Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8
Santa Cruz A; Mendes-Frias A; Azarias-da-Silva M; André S; Oliveira AI; Pires O; Mendes M; Oliveira B; Braga M; Lopes JR; Domingues R; Costa R; Silva LN; Matos AR; Ângela C; Costa P; Carvalho A; Capela C; Pedrosa J; Castro AG; Estaquier J; Silvestre R
Nat Commun; 2023 Mar; 14(1):1772. PubMed ID: 36997530
[TBL] [Abstract][Full Text] [Related]
8. Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19.
Williams GP; Yu ED; Shapiro K; Wang E; Freuchet A; Frazier A; Lindestam Arlehamn CS; Sette A; da Silva Antunes R
Hum Immunol; 2024 May; 85(3):110770. PubMed ID: 38433036
[TBL] [Abstract][Full Text] [Related]
9. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females.
Jansen EB; Ostadgavahi AT; Hewins B; Buchanan R; Thivierge BM; Sganzerla Martinez G; Goncin U; Francis ME; Swan CL; Scruten E; Bell J; Darbellay J; Facciuolo A; Falzarano D; Gerdts V; Fenton ME; Hedlin P; Kelvin DJ; Kelvin AA
Sci Rep; 2024 Apr; 14(1):9854. PubMed ID: 38684819
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
Sherif ZA; Gomez CR; Connors TJ; Henrich TJ; Reeves WB;
Elife; 2023 Mar; 12():. PubMed ID: 36947108
[TBL] [Abstract][Full Text] [Related]
11. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
[TBL] [Abstract][Full Text] [Related]
12. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
[TBL] [Abstract][Full Text] [Related]
13. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
[TBL] [Abstract][Full Text] [Related]
14. Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not?
Joseph P; Singh I; Oliveira R; Capone CA; Mullen MP; Cook DB; Stovall MC; Squires J; Madsen K; Waxman AB; Systrom DM
Chest; 2023 Sep; 164(3):717-726. PubMed ID: 37054777
[TBL] [Abstract][Full Text] [Related]
15. Persistent CD8
LaVergne SM; Dutt TS; McFann K; Baxter BA; Webb TL; Berry K; Tipton M; Stromberg S; Sullivan BM; Dunn J; Henao-Tamayo M; Ryan EP
Front Immunol; 2023; 14():1303971. PubMed ID: 38327763
[TBL] [Abstract][Full Text] [Related]
16. Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population.
Tannous J; Pan AP; Potter T; Bako AT; Dlouhy K; Drews A; Sostman HD; Vahidy FS
BMJ Open; 2023 Apr; 13(4):e067611. PubMed ID: 37019490
[TBL] [Abstract][Full Text] [Related]
17. Multiple early factors anticipate post-acute COVID-19 sequelae.
Su Y; Yuan D; Chen DG; Ng RH; Wang K; Choi J; Li S; Hong S; Zhang R; Xie J; Kornilov SA; Scherler K; Pavlovitch-Bedzyk AJ; Dong S; Lausted C; Lee I; Fallen S; Dai CL; Baloni P; Smith B; Duvvuri VR; Anderson KG; Li J; Yang F; Duncombe CJ; McCulloch DJ; Rostomily C; Troisch P; Zhou J; Mackay S; DeGottardi Q; May DH; Taniguchi R; Gittelman RM; Klinger M; Snyder TM; Roper R; Wojciechowska G; Murray K; Edmark R; Evans S; Jones L; Zhou Y; Rowen L; Liu R; Chour W; Algren HA; Berrington WR; Wallick JA; Cochran RA; Micikas ME; ; Wrin T; Petropoulos CJ; Cole HR; Fischer TD; Wei W; Hoon DSB; Price ND; Subramanian N; Hill JA; Hadlock J; Magis AT; Ribas A; Lanier LL; Boyd SD; Bluestone JA; Chu H; Hood L; Gottardo R; Greenberg PD; Davis MM; Goldman JD; Heath JR
Cell; 2022 Mar; 185(5):881-895.e20. PubMed ID: 35216672
[TBL] [Abstract][Full Text] [Related]
18. Neurological post-acute sequelae of SARS-CoV-2 infection.
Takao M; Ohira M
Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2.
Littlefield KM; Watson RO; Schneider JM; Neff CP; Yamada E; Zhang M; Campbell TB; Falta MT; Jolley SE; Fontenot AP; Palmer BE
PLoS Pathog; 2022 May; 18(5):e1010359. PubMed ID: 35617421
[TBL] [Abstract][Full Text] [Related]
20. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.
Peluso MJ; Spinelli MA; Deveau TM; Forman CA; Munter SE; Mathur S; Tang AF; Lu S; Goldberg SA; Arreguin MI; Hoh R; Tai V; Chen JY; Martinez EO; Yee BC; Chenna A; Winslow JW; Petropoulos CJ; Sette A; Weiskopf D; Kumar N; Lynch KL; Hunt PW; Durstenfeld MS; Hsue PY; Kelly JD; Martin JN; Glidden DV; Gandhi M; Deeks SG; Rutishauser RL; Henrich TJ
AIDS; 2022 Oct; 36(12):F7-F16. PubMed ID: 35866847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
